Description: Gemini Therapeutics, Inc., a precision medicine company, focuses on the development of new therapies for patients suffering from dry AMD and linked diseases. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Home Page: www.geminitherapeutics.com
GMTX Technical Analysis
300 One Kendall Square
Cambridge,
MA
02139
United States
Phone:
617 401 4400
Officers
| Name | Title |
|---|---|
| Dr. Georges Gemayel C.F.A., Ph.D. | Interim Pres & CEO and Exec. Chairperson |
| Mr. Brian Piekos | Chief Bus. Officer, CFO, Principal Accounting & Principal Financial Officer |
| Mr. Jason Patrick Meyenburg M.B.A., M.D. | Advisor |
| Mr. Patrick Truesdell | VP of Fin. & Controller |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6837 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-08-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 24 |